Discover Lantern Pharma's transformative 2024 journey in precision oncology with AI breakthroughs, global trial expansions, and key clinical milestones ...

Targeted therapies have significantly improved outcomes for patients with non-small cell lung cancer (NSCLC) with actionable mutations. However, many tumors inevitably develop drug resistance and ...

Full-year results and business updateClinical proof of principle obtained in Phase I adjuvant head and neck cancer trial with individualized ...

Analysts at HC Wainwright boosted their FY2025 EPS estimates for Moleculin Biotech in a report released on Monday, March 24th ...

Good morning and welcome to PDS Biotech's 4th quarter in full year 2024 earnings conference call. Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's 2024 results and clinical ...

HyFarm's Vigyaanshalas in Gujarat aim to improve potato quality, yield, and sustainability through innovative farming ...

Fatshark has today released a new update for Warhammer 40,000: Darktide. Titled Nightmares & Visions, this free update brings ...

India has developed its first indigenously manufactured MRI machine, which is set to be installed at AIIMS Delhi by October for trial runs, news agency ANI reported. This initiative is aimed to cut ...

Perspective Therapeutics (NYSE:CATX – Free Report) had its price target cut by Royal Bank of Canada from $16.00 to $15.00 in ...

Randomized-controlled Phase 3 trial, SUPRAME, to evaluate ACTengine® IMA203 TCR-T (PRAME) in advanced melanoma patients; first patient randomized and enrollment continues as plannedACTengine® IMA203 T ...

Unravel the complexities of filing a motorcycle accident lawsuit in Orlando and discover how the right legal steps can impact ...

“We recognized to compete with some of the best, we needed to make a change of some kind,” skip Kate Cameron told The Winnipeg Sun. “When Harris became available, it was very clear and apparent that ...